Einzeltreffer — DigiBib

Biological membranes, including plasma membrane (PM) and organelle membranes, restrict the flux of ions, molecules and organelles. However, the barrier function of biological membranes is frequently compromised by various perturbations, including physical membrane damage and protein- or chemical-induced pore formation. Recent evidence suggests that, upon PM damage, protein gelation and solid condensation are utilized to restrict ion/molecule/organelle flux across the damaged membranes by zoning the cytoplasm. In addition, membrane permeabilization dramatically alters intramembrane and extramembrane ion/molecule concentrations via the flux across the permeabilized membrane. The changes in ion/molecule concentration and their downstream pathways induce protein phase transition to form zones for biological processes or protein sequestration. Here, we review the mechanisms and functions of protein phase transition after biological membrane permeabilization.

Titel:	Cytoplasmic zoning by protein phase transition after membrane permeabilization.
Autor/in / Beteiligte Person:	Sugiyama, S ; Suda, K ; Kono, K
Zeitschrift:	Journal of biochemistry, Jg. 175 (2024-02-25), Heft 2, S. 147-153
Veröffentlichung:	<Nov. 2008->: Abingdon, UK : Oxford University Press ; <i>Original Publication</i>: Tokyo : Japanese Biochemical Society, 2024
Medientyp:	academicJournal
ISSN:	1756-2651 (electronic)
DOI:	10.1093/jb/mvad094
Schlagwort:	Cell Membrane metabolism Cytoplasm metabolism Cell Membrane Permeability Proteins metabolism Organelles metabolism
Sonstiges:	Nachgewiesen in: MEDLINE Sprachen: English Publication Type: Review; Journal Article Language: English [J Biochem] 2024 Feb 25; Vol. 175 (2), pp. 147-153. MeSH Terms: Proteins* / metabolism ; Organelles* / metabolism ; Cell Membrane / metabolism ; Cytoplasm / metabolism ; Cell Membrane Permeability References: Biochem Pharmacol. 2021 May;187:114385. (PMID: 33359010) ; Nat Rev Mol Cell Biol. 2023 May;24(5):312-333. (PMID: 36543934) ; Nature. 2006 Mar 9;440(7081):228-32. (PMID: 16407890) ; Proc Natl Acad Sci U S A. 2012 Jul 10;109(28):E1980-9. (PMID: 22733783) ; Nat Med. 2014 Feb;20(2):130-8. (PMID: 24504409) ; Proc Natl Acad Sci U S A. 2017 Aug 8;114(32):8574-8579. (PMID: 28743755) ; Cell. 2014 Mar 13;156(6):1193-1206. (PMID: 24630722) ; Methods Mol Biol. 2015;1266:29-53. (PMID: 25560066) ; Biophys Rev. 2019 Dec;11(6):927-994. (PMID: 31734826) ; Nat Rev Mol Cell Biol. 2020 Aug;21(8):439-458. (PMID: 32372019) ; Acta Neuropathol. 2017 Oct;134(4):629-653. (PMID: 28527044) ; Nat Mater. 2003 Sep;2(9):600-3. (PMID: 12942070) ; Nat Commun. 2021 Mar 1;12(1):1353. (PMID: 33649309) ; Front Chem. 2016 Feb 01;4:3. (PMID: 26870725) ; Physiol Rev. 2003 Apr;83(2):475-579. (PMID: 12663866) ; Elife. 2016 Mar 22;5:. (PMID: 27003292) ; Nat Commun. 2012;3:1285. (PMID: 23250415) ; Science. 2018 Feb 23;359(6378):. (PMID: 29472455) ; Biochim Biophys Acta. 2011 Oct;1810(10):933-44. (PMID: 21421024) ; Curr Biol. 2021 Jan 25;31(2):271-282.e5. (PMID: 33186551) ; Genetics. 2012 Aug;191(4):1041-72. (PMID: 22879407) ; J Exp Bot. 2014 Apr;65(7):1879-93. (PMID: 24591057) ; Immunity. 2013 Jun 27;38(6):1142-53. (PMID: 23809161) ; Proc Natl Acad Sci U S A. 2012 Sep 25;109(39):15781-6. (PMID: 22955885) ; Fungal Genet Biol. 2017 Dec;109:53-55. (PMID: 29107012) ; Cell Microbiol. 2017 Nov;19(11):. (PMID: 28671740) ; Eukaryot Cell. 2007 Jan;6(1):84-94. (PMID: 17099082) ; Sci Adv. 2021 Sep 17;7(38):eabf4468. (PMID: 34524838) ; Int J Mol Sci. 2018 Aug 04;19(8):. (PMID: 30081572) ; Cell Rep. 2023 Apr 25;42(4):112315. (PMID: 37019112) ; Cell. 2009 Aug 7;138(3):525-36. (PMID: 19665974) ; Trends Biochem Sci. 2014 Jun;39(6):260-7. (PMID: 24775734) ; Cell. 2013 Jul 3;154(1):134-45. (PMID: 23791384) ; J Biochem. 2014 Jun;155(6):345-51. (PMID: 24711463) ; Biochim Biophys Acta Mol Cell Biol Lipids. 2021 Aug;1866(8):158956. (PMID: 33932584) ; Cell Rep. 2023 Feb 28;42(2):112037. (PMID: 36701233) ; J Leukoc Biol. 2009 Nov;86(5):1227-38. (PMID: 19675207) ; Science. 2018 Jan 5;359(6371):. (PMID: 29301985) ; EMBO Rep. 2019 Oct 4;20(10):e48014. (PMID: 31432621) ; Cell. 2022 Nov 23;185(24):4488-4506.e20. (PMID: 36318922) ; EMBO J. 2021 Apr 1;40(7):e106922. (PMID: 33644904) ; Cell. 2022 Oct 27;185(22):4082-4098.e22. (PMID: 36198318) ; Plant Cell Environ. 2012 Aug;35(8):1419-27. (PMID: 22348276) ; Dev Cell. 2022 Jan 24;57(2):228-245.e6. (PMID: 35016014) ; Curr Biol. 2017 Dec 18;27(24):R1330-R1341. (PMID: 29257971) ; Nat Struct Biol. 2003 Apr;10(4):264-70. (PMID: 12640443) ; Science. 2018 Aug 17;361(6403):704-709. (PMID: 29976794) ; J Immunol. 2015 Aug 15;195(4):1685-97. (PMID: 26195813) ; Elife. 2023 May 19;12:. (PMID: 37204294) ; Elife. 2014 Apr 25;:. (PMID: 24771766) Grant Information: JPMJPF2205 JST COI-NEXT; 22 J21762 JSPS KAKENHI Contributed Indexing: Keywords: cellular wound healing; cytoplasmic zoning; liquid–liquid phase separation; membrane permeabilization; phase transition Substance Nomenclature: 0 (Proteins) Entry Date(s): Date Created: 20231116 Date Completed: 20240219 Latest Revision: 20240219 Update Code: 20240219 PubMed Central ID: PMC10873517

Klicken Sie ein Format an und speichern Sie dann die Daten oder geben Sie eine Empfänger-Adresse ein und lassen Sie sich per Email zusenden.

BibTeX Citavi, JabRef, u.a.
(Literaturverwaltung)

PDF kein Volltext!
(Merkzettel, Notizen)

RIS Endnote, Citavi u.a.
(Literaturverwaltung)

MODS
(XML zur Weiterverarbeitung)

oder

Wählen Sie das für Sie passende Zitationsformat und kopieren Sie es dann in die Zwischenablage, lassen es sich per Mail zusenden oder speichern es als PDF-Datei.

Gewünschter Zitations-Stil:

oder

Bitte prüfen Sie, ob die Zitation formal korrekt ist, bevor Sie sie in einer Arbeit verwenden. Benutzen Sie gegebenenfalls den "Exportieren"-Dialog, wenn Sie ein Literaturverwaltungsprogramm verwenden und die Zitat-Angaben selbst formatieren wollen.

Cytoplasmic zoning by protein phase transition after membrane permeabilization.